Evidence map›Paper›PMID 25370894›Full record

ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2015

Obstacles to adherence to azacitidine administration schedule in outpatient myelodysplastic syndrome and related disorders.

Andrea Tendas, Maria Felicita Lissia, Daniela Piccioni, Liliana Tirimbelli, Laura Scaramucci, Marco Giovannini, Teresa Dentamaro, Alessio Perrotti, Paolo de Fabritiis, Pasquale Niscola

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Oral hypomethylating agents: beyond convenience in MDS.Hematology. American Society of Hematology. Education Program · 2021
    Article
  3. Article
  4. Azacitidine in outpatient treatment - single center experience.Contemporary oncology (Poznan, Poland) · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Andrea TendasHematology Unit and Department of Pharmacy Services, Sant'Eugenio Hospital, Rome, Italy.
Maria Felicita Lissia
Daniela Piccioni
Liliana Tirimbelli
Laura Scaramucci
Marco Giovannini
Teresa Dentamaro
Alessio Perrotti
Paolo de Fabritiis
Pasquale Niscola
St. Eugenio Hospital · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Medication AdherenceAdultAgedAged, 80 and overAntimetabolites, AntineoplasticAzacitidineDrug Administration ScheduleFemaleHumansMaleMiddle AgedMyelodysplastic SyndromesOutpatientsAntimetabolites, AntineoplasticAzacitidine

Identifiers

PMID25370894
OpenAlexW1991148307

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.